Patents by Inventor Prabhu Prasad Mohapatra

Prabhu Prasad Mohapatra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Arylpiperazine derivatives and methods of utilizing same
    Patent number: 9975862
    Abstract: The present invention provides arylpiperazine derivatives having Formula I as shown below, which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression,
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: May 22, 2018
    Assignee: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
  • ARYLPIPERAZINE DERIVATIVES AND METHODS OF UTILIZING SAME
    Publication number: 20170327477
    Abstract: The present invention provides arylpiperazine derivatives having Formula I as shown below, which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression,
    Type: Application
    Filed: March 27, 2017
    Publication date: November 16, 2017
    Inventors: Laxminarayan BHAT, Prabhu Prasad MOHAPATRA, Kouacou ADIEY
  • Arylpiperazine derivatives and methods of utilizing same
    Patent number: 9604944
    Abstract: The present invention provides arylpiperazine derivatives having Formula 1a as shown below, which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression,
    Type: Grant
    Filed: February 8, 2016
    Date of Patent: March 28, 2017
    Assignee: REVIVA PHARMACEUTICALS, INC.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
  • ARYLPIPERAZINE DERIVATIVES AND METHODS OF UTILIZING SAME
    Publication number: 20160229821
    Abstract: The present invention provides arylpiperazine derivatives having Formula I as shown below, which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression,
    Type: Application
    Filed: February 8, 2016
    Publication date: August 11, 2016
    Inventors: Laxminarayan BHAT, Prabhu Prasad MOHAPATRA, Kouacou ADIEY
  • Arylpiperazine derivatives and methods of utilizing same
    Patent number: 9255076
    Abstract: The present invention provides arylpiperazine derivatives having Formula I as shown below, which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression,
    Type: Grant
    Filed: February 24, 2015
    Date of Patent: February 9, 2016
    Assignee: REVIVA PHARMACEUTICALS, INC.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
  • ARYLPIPERAZINE DERIVATIVES AND METHODS OF UTILIZING SAME
    Publication number: 20150166493
    Abstract: The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression.
    Type: Application
    Filed: February 24, 2015
    Publication date: June 18, 2015
    Inventors: Laxminarayan BHAT, Prabhu Prasad MOHAPATRA, Kouacou ADIEY
  • Arylpiperazine derivatives and methods of utilizing same
    Patent number: 8980883
    Abstract: The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression.
    Type: Grant
    Filed: September 17, 2014
    Date of Patent: March 17, 2015
    Assignee: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
  • ARYLPIPERAZINE DERIVATIVES AND METHODS OF UTILIZING SAME
    Publication number: 20150005298
    Abstract: The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression.
    Type: Application
    Filed: September 17, 2014
    Publication date: January 1, 2015
    Inventors: Laxminarayan BHAT, Prabhu Prasad MOHAPATRA, Kouacou ADIEY
  • Methods of utilizing arylpiperazine derivatives
    Patent number: 8859552
    Abstract: The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression.
    Type: Grant
    Filed: June 10, 2013
    Date of Patent: October 14, 2014
    Assignee: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
  • METHODS OF UTILIZING ARYLPIPERAZINE DERIVATIVES
    Publication number: 20140155392
    Abstract: The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression.
    Type: Application
    Filed: June 10, 2013
    Publication date: June 5, 2014
    Applicant: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
  • Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
    Patent number: 8580822
    Abstract: The present invention provides novel indanone derivatives which can be advantageously used for treating and/or preventing of a medical condition for which inhibition of a cholinesterase is desired.
    Type: Grant
    Filed: June 8, 2012
    Date of Patent: November 12, 2013
    Assignee: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra
  • Compositions, synthesis, and methods of utilizing quinazolinedione derivatives
    Patent number: 8575185
    Abstract: The present invention provides quinazolinedione derivatives of Formulae Ia and Ib, which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, depression and dementia.
    Type: Grant
    Filed: February 26, 2010
    Date of Patent: November 5, 2013
    Assignee: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Sureshbabu Dadiboyena, Kouacou Adiey
  • Methods of utilizing arylpiperazine derivatives
    Patent number: 8461154
    Abstract: The present invention provides arylpiperazine derivatives having Formula I which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder and depression.
    Type: Grant
    Filed: May 7, 2012
    Date of Patent: June 11, 2013
    Assignee: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
  • Methods of utilizing arylpiperazine derivatives
    Patent number: 8431570
    Abstract: The present invention provides arylpiperazine derivatives having Formula I which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder and depression.
    Type: Grant
    Filed: May 7, 2012
    Date of Patent: April 30, 2013
    Assignee: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
  • COMPOSITIONS, SYNTHESIS, AND METHODS OF USING INDANONE BASED CHOLINESTERASE INHIBITORS
    Publication number: 20120252842
    Abstract: The present invention provides novel indanone derivatives which can be advantageously used for treating and/or preventing of a medical condition for which inhibition of a cholinesterase is desired.
    Type: Application
    Filed: June 8, 2012
    Publication date: October 4, 2012
    Applicant: REVIVA PHARMACEUTICALS, INC.
    Inventors: Laxminarayan BHAT, Prabhu Prasad MOHAPATRA
  • METHODS OF UTILIZING ARYLPIPERAZINE DERIVATIVES
    Publication number: 20120220579
    Abstract: The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression.
    Type: Application
    Filed: May 7, 2012
    Publication date: August 30, 2012
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
  • METHODS OF UTILIZING ARYLPIPERAZINE DERIVATIVES
    Publication number: 20120220574
    Abstract: The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression.
    Type: Application
    Filed: May 7, 2012
    Publication date: August 30, 2012
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
  • Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
    Patent number: 8247563
    Abstract: The present invention provides novel indanone derivatives which can be advantageously used for treating and/or preventing of a medical condition for which inhibition of a cholinesterase is desired.
    Type: Grant
    Filed: December 11, 2007
    Date of Patent: August 21, 2012
    Assignee: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra
  • Compositions, synthesis, and methods of using piperazine based antipsychotic agents
    Patent number: 8207163
    Abstract: The present invention provides novel piperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder and depression.
    Type: Grant
    Filed: May 27, 2009
    Date of Patent: June 26, 2012
    Assignee: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
  • Compositions, synthesis, and methods of utilizing arylpiperazine derivatives
    Patent number: 8188076
    Abstract: The present invention provides arylpiperazine derivatives having Formula I which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder and depression.
    Type: Grant
    Filed: February 26, 2010
    Date of Patent: May 29, 2012
    Assignee: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey